Proactive Use of High-Flow Nasal Cannula With Critically Ill Subjects.

INTRODUCTION: It has been suggested that use of a high-flow nasal cannula (HFNC) could be a first-line therapy for patients with acute hypoxic respiratory failure. The purpose of this study was to determine if protocolized use of HFNC decreases unplanned intubation and adverse outcomes in an ICU pop...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 63; no. 3; pp. 259 - 267
Autores principales: Lamb, Keith D., Spilman, Sarah K., Oetting, Trevor W., Jackson, Julie A., Trump, Matthew W., Sahr, Sheryl M.
Formato: CEU research tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. Mar2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128238627&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128238627
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Mar2018
      vid: 63
      iid: 3
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        128238627
        128238627
        128238627
        10.4187/respcare.05793
        128238627
      ppf: 259
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Proactive Use of High-Flow Nasal Cannula With Critically Ill Subjects.
      aug:
        au:
          Lamb, Keith D.
          Spilman, Sarah K.
          Oetting, Trevor W.
          Jackson, Julie A.
          Trump, Matthew W.
          Sahr, Sheryl M.
        affil: Department of Respiratory Therapy, UnityPoint Health, Des Moines, Iowa
      sug:
        subj:
          Nasal Cannula Utilization
          Critically Ill Patients
          Oxygen Therapy
          Respiratory Failure Prevention and Control
          Education, Continuing (Credit)
          Human
          Descriptive Statistics
          Protocols
          Intubation
          Intensive Care Units
          Prospective Studies
          Retrospective Design
          Hospital Mortality
          Length of Stay
          P-Value
          Gram-Negative Bacterial Infections
          Lung
          Extubation
          Time Factors
          Bronchodilator Agents Therapeutic Use
          Iowa
          Respiration, Artificial
          Data Analysis Software
          Kruskal-Wallis Test
          One-Way Analysis of Variance
          Chi Square Test
          Middle Age
          Aged
          Male
          Female
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: INTRODUCTION: It has been suggested that use of a high-flow nasal cannula (HFNC) could be a first-line therapy for patients with acute hypoxic respiratory failure. The purpose of this study was to determine if protocolized use of HFNC decreases unplanned intubation and adverse outcomes in an ICU population. METHODS: The study was a prospective evaluation of 2 cohorts who received HFNC per protocol. Control groups were retrospective selections of subjects who received HFNC in the pre-protocol period. Cohort 1 (n = 88) received mechanical ventilation for ≥ 24 h and was extubated directly to HFNC following strict protocol criteria. Cohort 2 (n = 83) were placed on HFNC when oxygen requirements escalated (>4 L/min). RESULTS: Cohort 1 did not differ from its control group in mortality, hospital stay, or ICU days, but there were significant decreases in incidence of Gram-negative pulmonary infection (30% vs 9%, P = .001) and use of bronchodilator therapy (81% vs 61%, P = .008). Failed extubation rates were nearly identical across groups, but time to re-intubation was shorter in the protocol group (24 vs 13 h, P = .19). Cohort 2 did not differ significantly from its control group in intubation rates or mortality, but subjects managed by protocol experienced significant decreases in ICU days (4 vs 3 d, P = .03) and hospital days (12 vs 8 d, P = .007). There was a trend toward fewer hours on HFNC (33 vs 24 h, P = .10) and faster time to intubation when HFNC failed (19 vs 9 h, P = .08). CONCLUSIONS: Extubation to HFNC led to a significant decrease in pulmonary infections and bronchodilator therapy in Cohort 1 but did not reduce length of stay or rates of failed extubation. When HFNC was used early and per protocol (Cohort 2), ICU and hospital lengths of stay were reduced and HFNC was initiated more quickly when the need for respiratory support escalated.
      pubtype: Academic Journal
      doctype:
        CEU
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N